The primary objective is to explore if HRS8179 could improve midline shift at 72 hours (or at time of decompressive craniectomy or comfort measures only, if earlier) in participants with large hemispheric infarction. The secondary objective is to explore if HRS8179 could improve acute neurologic status, functional outcomes, treatment requirements and safety.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
40
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China
The change between baseline and 72-78 hours in midline shift measured by MRI or CT
Time frame: Baseline up to 72 hours
modified Rankin Scale (mRS) Score
Time frame: Day 90
Overall survival
Time frame: Baseline up to Day 90
Number of Participants Who Achieved mRS 0-4
Time frame: Day 90
Adverse Events (AEs) and Serious Adverse Events (SAEs)
Time frame: Baseline up to Day 90
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.